# CLAUDE DEEP RESEARCH REPORT - SHORGAN-BOT

## Week of December 26, 2025

### Generated: 2025-12-26 at 11:43 AM ET

### Model: Claude Opus 4.1 with Extended Thinking (Anthropic)

### Portfolio Value: $113,692.01

---

I'll analyze this portfolio and generate a comprehensive catalyst-driven trading report. Let me gather key data on positions and market conditions.---

# SHORGAN-BOT WEEKLY CATALYST RESEARCH REPORT
**Week 17 | December 22-26, 2025**

---

## 1. PORTFOLIO SNAPSHOT

- **Total Value**: $113,692.01
- **Cash Available**: $19,353.41 
- **Positions**: 20 long, 7 short
- **Unrealized P&L**: +$5,821.44 (+5.4%)
- **Buying Power**: $170,856.35

**Holdings Summary Table:**
| Ticker | Shares | Side | Avg Entry | Current | Value | P&L ($) | P&L (%) |
|--------|--------|------|-----------|---------|-------|---------|---------|
| ZM | 400 | LONG | $88.62 | $87.92 | $35,168 | -$278.50 | -0.8% |
| CVX | 93 | SHORT | $157.27 | $150.16 | $13,965 | +$660.77 | +4.5% |
| DAKT | 743 | SHORT | $19.81 | $18.54 | $13,771 | +$947.33 | +6.4% |
| PLUG | 5000 | LONG | $2.07 | $2.10 | $10,475 | +$110.23 | +1.1% |
| DOCU | 140 | LONG | $65.45 | $69.62 | $9,747 | +$583.80 | +6.4% |
| ENPH | 300 | LONG | $31.22 | $32.88 | $9,864 | +$498.03 | +5.3% |
| MFIC | 770 | LONG | $12.16 | $11.46 | $8,828 | -$535.15 | -5.7% |
| RIVN | 400 | LONG | $21.68 | $21.09 | $8,434 | -$238.00 | -2.7% |
| SOFI | 300 | LONG | $25.90 | $27.45 | $8,234 | +$463.50 | +6.0% |
| BEAM | 300 | LONG | $27.29 | $27.42 | $8,226 | +$39.00 | +0.5% |
| SPY | 10 | LONG | $649.10 | $690.30 | $6,903 | +$411.98 | +6.3% |
| ABNB | 50 | SHORT | $132.15 | $136.36 | $6,818 | -$210.50 | -3.2% |
| NU | 400 | LONG | $15.63 | $16.66 | $6,662 | +$410.00 | +6.6% |
| INCY | 61 | LONG | $83.97 | $99.85 | $6,091 | +$968.68 | +18.9% |
| SMCI | 200 | LONG | $31.47 | $30.48 | $6,095 | -$199.17 | -3.2% |
| RIG | 1500 | LONG | $3.88 | $3.99 | $5,985 | +$172.65 | +3.0% |
| NCNO | 174 | SHORT | $29.72 | $25.95 | $4,515 | +$655.98 | +12.7% |
| GKOS | 30 | LONG | $87.95 | $116.00 | $3,480 | +$841.35 | +31.9% |
| GPK | 142 | SHORT | $17.77 | $15.09 | $2,142 | +$381.27 | +15.1% |
| ARQT | 70 | LONG | $19.98 | $29.20 | $2,044 | +$645.12 | +46.1% |
| CIVI | 76 | SHORT | $28.56 | $26.66 | $2,026 | +$144.40 | +6.7% |
| ARWR | 24 | LONG | $40.25 | $69.99 | $1,680 | +$713.76 | +73.9% |
| EMBC | 68 | SHORT | $14.15 | $11.94 | $812 | +$150.28 | +15.6% |
| BYND | 500 | LONG | $0.98 | $0.95 | $474 | -$16.36 | -3.3% |

---

## 2. MARKET ENVIRONMENT & CATALYST LANDSCAPE (December 26, 2025)

**Market Regime**: HOLIDAY DRIFT / LIGHT VOLUME

**Index Levels & Analysis:**
- **SPY**: $690.28 | Bid/Ask: $690.19/$690.44 | Holiday grind higher continues
- **QQQ**: $624.43 | Bid/Ask: $624.46/$624.47 | Tech leading on AI optimism
- **IWM**: $251.16 | Bid/Ask: $251.18/$251.20 | Small caps lagging (bearish divergence)
- **TLT**: $87.66 | Bonds weak on sticky inflation concerns

**Key Market Dynamics:**
- Holiday week = LOW VOLUME WARNING (setups may fail)
- January 2026 effect approaching - tax loss selling wrapping up
- Quantum computing bubble forming (IONQ $46.93, RGTI $23.14, QBTS $25.46)
- AI momentum intact but extended
- Energy shorts working (CVX short +4.5%)
- Small cap biotech heating up again

**Volatility Assessment:**
- VIX likely ~14-15 (no direct data) = Complacency zone
- Low IV environment = Buy premium strategies challenged
- Holiday vol crush = Short premium opportunities

**Critical Upcoming Catalysts (Next 14 Days):**
1. January 7-10: JPM Healthcare Conference (biotech bonanza)
2. January 15: December CPI data (inflation watch)
3. January 29: FOMC meeting (first of 2026)
4. Q4 earnings season kickoff mid-January

**Sector Momentum Rankings:**
1. **QUANTUM COMPUTING**: Parabolic (short candidates)
2. **AI/SOFTWARE**: Strong but extended
3. **BIOTECH**: Waking up pre-JPM conference
4. **ENERGY**: Weak (shorts working)
5. **CHINA TECH**: Dead money

**Short Squeeze Watch:**
- BYND: 37% short interest (but already crushed)
- PLUG: High short interest + hydrogen catalysts
- ABNB: Building short base

---

## 3. CATALYST CALENDAR (Next 14 Trading Days)

**December 27-31, 2025 (Next Week):**
```
[12/30] - Market Holiday Schedule
  Type: Low Volume
  Expected Impact: Low
  Trade Setup: Avoid new positions

[12/31] - Year-End Window Dressing
  Type: Institutional Flows  
  Expected Impact: Medium
  Trade Setup: Fade extreme moves
```

**January 2-10, 2026:**
```
[1/3] - December Jobs Report
  Type: Economic Data
  Expected Impact: High
  Trade Setup: SPY straddle if VIX <14

[1/7-10] - JPM Healthcare Conference
  Type: Biotech Catalyst Bonanza
  Expected Impact: HIGH
  Trade Setup: Long ARWR, XBI calls

[1/8] - CES 2026 (Tech Conference)
  Type: Product Launches
  Expected Impact: Medium
  Trade Setup: Tech momentum plays

[1/9] - Bank Earnings Start (JPM, C, WFC)
  Type: Earnings
  Expected Impact: High
  Trade Setup: XLF options
```

**Priority Biotech Catalysts:**
- BEAM: Gene editing updates at JPM
- ARWR: RNAi pipeline presentation
- Multiple FDA PDUFA dates in January

---

## 4. POSITION-BY-POSITION ANALYSIS

### ZM - Zoom Video
**Thesis Status**: BROKEN (overweight disaster)

**Position Details**:
- Shares: 400 @ $88.62 (LONG)
- Current: $87.92 | P&L: -$278.50 (-0.8%)
- Allocation: 30.9% of portfolio (CRITICAL OVERWEIGHT)

**Catalyst Status**: None pending

**Technical Setup**: Failed breakout, support at $85

**Action**: EXIT 300 SHARES IMMEDIATELY

**Justification**:
1. Fundamental: No catalyst, dead money
2. Technical: Failed at $91 resistance
3. Risk: 30.9% position = UNACCEPTABLE concentration

### ARWR - Arrowhead Pharmaceuticals
**Thesis Status**: STRONG (massive winner)

**Position Details**:
- Shares: 24 @ $40.25 (LONG)  
- Current: $69.99 | P&L: +$713.76 (+73.9%)
- Allocation: 1.5% of portfolio

**Catalyst Status**: JPM Healthcare Conference Jan 7-10

**Technical Setup**: Parabolic move, extended

**Action**: TRIM 12 SHARES (take profits)

**Justification**:
1. Fundamental: Pipeline advancing
2. Technical: Way overbought RSI >75
3. Risk: Lock in gains, keep runners for JPM

### ARQT - Arcutis Biotherapeutics
**Thesis Status**: STRONG 

**Position Details**:
- Shares: 70 @ $19.98 (LONG)
- Current: $29.20 | P&L: +$645.12 (+46.1%)
- Allocation: 1.8% of portfolio

**Catalyst Status**: Dermatology data Q1 2026

**Technical Setup**: Breakout continuation

**Action**: TRIM 35 SHARES

**Justification**:
1. Up 46% = Take partial profits
2. Keep half for Q1 catalyst
3. Biotech momentum intact

### GKOS - Glaukos Corp
**Thesis Status**: INTACT

**Position Details**:
- Shares: 30 @ $87.95 (LONG)
- Current: $116.00 | P&L: +$841.35 (+31.9%)
- Allocation: 3.1% of portfolio

**Catalyst Status**: Ophthalmic device approvals 2026

**Technical Setup**: Strong uptrend

**Action**: TRIM 15 SHARES

**Justification**:
1. 32% gain = Partial profit mandate
2. Medical device strength continues
3. Keep runners for 2026 catalysts

### INCY - Incyte
**Thesis Status**: INTACT

**Position Details**:
- Shares: 61 @ $83.97 (LONG)
- Current: $99.85 | P&L: +$968.68 (+18.9%)
- Allocation: 5.4% of portfolio

**Catalyst Status**: JAK inhibitor data Q1

**Technical Setup**: Approaching $100 resistance

**Action**: HOLD (approaching catalyst)

### CVX - Chevron (SHORT)
**Thesis Status**: STRONG

**Position Details**:
- Shares: 93 @ $157.27 (SHORT)
- Current: $150.16 | P&L: +$660.77 (+4.5%)
- Allocation: -12.3% of portfolio

**Catalyst Status**: Oil weakness continues

**Technical Setup**: Breakdown below $150

**Action**: HOLD SHORT

**Justification**:
1. Energy sector weakness intact
2. Target $145
3. Stop at $155

### DAKT - Daktronics (SHORT)
**Thesis Status**: INTACT

**Position Details**:
- Shares: 743 @ $19.81 (SHORT)
- Current: $18.54 | P&L: +$947.33 (+6.4%)
- Allocation: -12.1% of portfolio

**Catalyst Status**: Earnings late January

**Technical Setup**: Downtrend continuation

**Action**: HOLD SHORT

### PLUG - Plug Power
**Thesis Status**: WEAKENING

**Position Details**:
- Shares: 5000 @ $2.07 (LONG)
- Current: $2.10 | P&L: +$110.23 (+1.1%)
- Allocation: 9.2% of portfolio

**Catalyst Status**: Hydrogen economy hopes

**Technical Setup**: Range-bound $2.00-2.50

**Action**: TRIM 2500 SHARES

**Justification**:
1. No near-term catalyst
2. Reduce exposure to speculative plays
3. Keep half for hydrogen lottery ticket

### DOCU - DocuSign
**Thesis Status**: INTACT

**Position Details**:
- Shares: 140 @ $65.45 (LONG)
- Current: $69.62 | P&L: +$583.80 (+6.4%)
- Allocation: 8.6% of portfolio

**Catalyst Status**: Earnings March 2026

**Technical Setup**: Bullish consolidation

**Action**: HOLD

### ABNB - Airbnb (SHORT)
**Thesis Status**: CHALLENGED

**Position Details**:
- Shares: 50 @ $132.15 (SHORT)
- Current: $136.36 | P&L: -$210.50 (-3.2%)
- Allocation: -6.0% of portfolio

**Catalyst Status**: Travel weakness thesis

**Technical Setup**: Stop approaching at $140

**Action**: HOLD WITH TIGHT STOP

### SMCI - Super Micro Computer
**Thesis Status**: INTACT

**Position Details**:
- Shares: 200 @ $31.47 (LONG)
- Current: $30.48 | P&L: -$199.17 (-3.2%)
- Allocation: 5.4% of portfolio

**Catalyst Status**: Accounting clarity + AI demand

**Technical Setup**: Base building $29-32

**Action**: HOLD

### REMAINING POSITIONS - QUICK ASSESSMENT:

**HOLDS:**
- BEAM: Gene editing catalyst at JPM
- ENPH: Solar recovery play
- SOFI: Fintech momentum
- NU: Brazil growth story
- RIG: Oil services turnaround
- RIVN: EV lottery ticket
- SPY: Market hedge

**SHORTS TO MAINTAIN:**
- CIVI: Energy short working
- EMBC: Retail weakness
- GPK: Packaging headwinds
- NCNO: Fintech competition

**EXIT CANDIDATES:**
- MFIC: No catalyst, dead money (-5.7%)
- BYND: Bankruptcy watch, too risky

---

## 5. REBALANCING PLAN (Rules-Based)

**Rules Applied:**
| Rule | Condition | Threshold | Action |
|------|-----------|-----------|--------|
| EXIT | Overweight crisis | >30% allocation | Sell 75% of ZM |
| TRIM | Strong winner | >25% gain | Trim 50% winners |
| EXIT | No catalyst + loss | >30 days | Exit MFIC |
| EXIT | Bankruptcy risk | High risk | Exit BYND |
| COVER | Short at target | Target hit | Consider covers |

**Rebalancing Actions:**
| Ticker | Status | Rule | Action | Proceeds |
|--------|--------|------|--------|----------|
| ZM | OVERWEIGHT 30.9% | Crisis | Sell 300 shares | +$26,376 |
| ARWR | +73.9% gain | Winner | Sell 12 shares | +$840 |
| ARQT | +46.1% gain | Winner | Sell 35 shares | +$1,022 |
| GKOS | +31.9% gain | Winner | Sell 15 shares | +$1,740 |
| PLUG | No catalyst | Reduce | Sell 2500 shares | +$5,250 |
| MFIC | -5.7% no catalyst | Exit | Sell 770 shares | +$8,828 |
| BYND | Bankruptcy risk | Exit | Sell 500 shares | +$475 |

**Cash Flow:**
- Current Cash: $19,353.41
- From Exits: +$44,531.00
- **New Buying Power**: $63,884.41

---

## 6. CONVICTION SCORECARD

| Rank | Ticker | Score | Catalyst (40%) | Technicals (30%) | Fundamentals (30%) | Action |
|------|--------|-------|----------------|------------------|--------------------| -------|
| 1 | ARWR | 8.5 | JPM Conference (9.0) | Overbought (7.0) | Pipeline (9.0) | HOLD/TRIM |
| 2 | BEAM | 8.0 | JPM Conference (9.0) | Consolidating (7.0) | Gene editing (8.0) | HOLD |
| 3 | CVX | 7.5 | Oil weakness (8.0) | Breakdown (8.0) | Overvalued (6.5) | HOLD SHORT |
| 4 | DAKT | 7.5 | Earnings setup (7.0) | Downtrend (8.0) | Weak fundamentals (7.5) | HOLD SHORT |
| 5 | INCY | 7.0 | Q1 data (7.5) | Near resistance (6.0) | Strong pipeline (7.5) | HOLD |
| 6 | DOCU | 7.0 | Q4 earnings (6.0) | Uptrend (7.5) | Improving margins (7.5) | HOLD |
| 7 | SOFI | 6.5 | Fintech momentum (6.0) | Bullish (7.0) | Growth story (6.5) | HOLD |
| 8 | ENPH | 6.5 | Solar recovery (6.5) | Base building (6.0) | Sector rotation (7.0) | HOLD |
| 9 | NCNO | 6.0 | Competition (7.0) | Weak chart (7.0) | Deteriorating (4.0) | HOLD SHORT |
| 10 | GPK | 6.0 | Macro headwinds (6.0) | Downtrend (7.0) | Margins pressure (5.0) | HOLD SHORT |
| ... | ... | ... | ... | ... | ... | ... |
| 20 | ABNB | 4.5 | Travel slowdown (4.0) | Failed breakdown (4.0) | Expensive (5.5) | MONITOR STOP |
| 21 | ZM | 3.5 | None (2.0) | Failed breakout (4.0) | No growth (4.5) | EXIT |
| 22 | MFIC | 3.0 | None (2.0) | Weak (3.0) | Declining (4.0) | EXIT |
| 23 | BYND | 2.0 | Bankruptcy risk (1.0) | Collapse (2.0) | Terrible (3.0) | EXIT |

**Bottom 3 = EXIT | Top new ideas below**

---

## 7. TOP CATALYST OPPORTUNITIES 

### IONQ - IonQ Inc (SHORT SETUP)
**Catalyst**: Quantum bubble bursting, lockup expiration February 2026

**Setup**:
- Current: $46.93 | Entry: $47-50 
- Stop: $55.00 | Target 1: $35.00 | Target 2: $25.00
- Position Size: 150 shares SHORT (~$7,050 / 6.2% of portfolio)

**Risk/Reward**:
- Bear case (60%): +$1,785 at $35 target
- Bull case (40%): -$1,200 (stop at $55)

**Conviction**: 8/10 - Parabolic move on hype, no revenue

### PATH - UiPath (LONG)
**Catalyst**: Automation AI adoption, earnings February 12, 2026

**Setup**:
- Current: $17.07 | Entry: $17.00
- Stop: $15.50 | Target 1: $20.00 | Target 2: $23.00
- Position Size: 400 shares (~$6,800 / 6% of portfolio)

**Risk/Reward**:
- Bull case (65%): +$1,200 at $20
- Bear case (35%): -$600 (stop)

**Conviction**: 7.5/10 - AI automation beneficiary

### XBI - Biotech ETF (LONG)
**Catalyst**: JPM Healthcare Conference January 7-10, 2026

**Setup**:
- Current: ~$95 | Entry: $94-95
- Stop: $90 | Target 1: $102 | Target 2: $108
- Position Size: 70 shares (~$6,650 / 5.8% of portfolio)

**Risk/Reward**:
- Bull case (70%): +$490 at $102
- Bear case (30%): -$350 (stop)

**Conviction**: 8/10 - Best way to play JPM conference

### MRNA - Moderna (LONG)
**Catalyst**: Cancer vaccine data Q1 2026, oversold bounce

**Setup**:
- Current: $31.31 | Entry: $31.00-31.50
- Stop: $28.00 | Target 1: $36.00 | Target 2: $40.00
- Position Size: 200 shares (~$6,300 / 5.5% of portfolio)

**Risk/Reward**:
- Bull case (60%): +$1,000 at $36
- Bear case (40%): -$700 (stop)

**Conviction**: 7/10 - Beaten down with catalysts

### RGTI - Rigetti Computing (SHORT)
**Catalyst**: Quantum bubble deflation, no real revenue

**Setup**:
- Current: $23.14 | Entry: $23-25
- Stop: $28.00 | Target 1: $15.00 | Target 2: $10.00
- Position Size: 250 shares SHORT (~$5,785 / 5% of portfolio)

**Risk/Reward**:
- Bear case (65%): +$2,000 at $15
- Bull case (35%): -$1,250 (stop)

**Conviction**: 8.5/10 - Pure bubble with no fundamentals

### AFRM - Affirm (LONG)
**Catalyst**: BNPL growth, partnership announcements

**Setup**:
- Current: $75.61 | Entry: $74-76
- Stop: $69.00 | Target 1: $85.00 | Target 2: $92.00
- Position Size: 80 shares (~$6,048 / 5.3% of portfolio)

**Risk/Reward**:
- Bull case (60%): +$800 at $85
- Bear case (40%): -$560 (stop)

**Conviction**: 7/10 - Fintech momentum play

### TSLA - Tesla (PUTS)
**Catalyst**: Deliveries disappoint, valuation reality check

**Setup**:
- Current: ~$480 | Put Entry: $460 strike February
- Premium: ~$15.00 | Contracts: 2
- Max Loss: $3,000 | Max Profit: $6,000
- Breakeven: $445

**Conviction**: 7.5/10 - Overvalued on robotaxi dreams

### OXY - Occidental (SHORT)
**Catalyst**: Oil weakness, Buffett selling

**Setup**:
- Current: ~$46 | Entry: $46-47
- Stop: $50 | Target 1: $42 | Target 2: $38
- Position Size: 150 shares SHORT (~$6,900 / 6% of portfolio)

**Risk/Reward**:
- Bear case (70%): +$600 at $42
- Bull case (30%): -$600 (stop)

**Conviction**: 8/10 - Energy sector weakness continues

---

## 8. SHORT OPPORTUNITIES

**Quantum Computing Bubble Shorts:**
1. **IONQ** @ $47-50 - Feb lockup, no revenue
2. **RGTI** @ $23-25 - Pure speculation
3. **QBTS** @ $25-27 - Another quantum joke

**Lockup Expiration Shorts (Priority):**
- **SMCI** puts for March - Accounting issues remain
- **APP** - January 15 lockup, momentum fading
- **KVUE** - Healthcare SPAC unlock February

**Overvalued Tech:**
- **SNOW** @ $220+ - Slowing growth
- **DDOG** @ $160+ - Competition rising

**Failed SPACs:**
- Watch for any SPAC >$15 with upcoming unlocks

---

## 9. OPTIONS STRATEGIES

### XBI CALL DEBIT SPREAD (JPM Play)
- Type: Bull Call Spread
- Buy: $95 Call Jan 17 @ $3.50
- Sell: $100 Call Jan 17 @ $1.50
- Net Debit: $2.00 | Contracts: 5
- Max Loss: $1,000 | Max Profit: $1,500
- Breakeven: $97.00
- Exit: Close at +50% or before JPM conference

### TSLA PUT SPREAD (Overvaluation)
- Type: Bear Put Spread  
- Buy: $460 Put Feb 21 @ $15.00
- Sell: $440 Put Feb 21 @ $8.00
- Net Debit: $7.00 | Contracts: 2
- Max Loss: $1,400 | Max Profit: $2,600
- Breakeven: $453.00
- Exit: +50% profit or delivery numbers

### IONQ BEAR CALL SPREAD (Bubble Short)
- Type: Credit Spread
- Sell: $50 Call Jan 31 @ $4.00
- Buy: $55 Call Jan 31 @ $2.00  
- Net Credit: $2.00 | Contracts: 5
- Max Loss: $1,500 | Max Profit: $1,000
- Breakeven: $52.00
- Exit: 50% of credit captured

### SPY COLLAR (Protection)
- Own: 10 SPY shares
- Buy: $680 Put Jan 31 @ $5.00
- Sell: $700 Call Jan 31 @ $3.00
- Net Debit: $2.00 ($200 total)
- Protection below $680, capped at $700

---

## 10. TRADE SUMMARY TABLE

| Ticker | Action | Type | Size | Entry | Catalyst | Stop | Target | Rationale |
|--------|--------|------|------|-------|----------|------|--------|-----------|
| ZM | SELL | EXIT | 300 | Market | Overweight | - | - | 30.9% concentration unacceptable |
| ARWR | SELL | TRIM | 12 | Market | Profit-take | - | - | +74% gain, reduce before JPM |
| ARQT | SELL | TRIM | 35 | Market | Profit-take | - | - | +46% gain, lock profits |
| GKOS | SELL | TRIM | 15 | Market | Profit-take | - | - | +32% gain, trim winner |
| PLUG | SELL | REDUCE | 2500 | Market | No catalyst | - | - | Dead money, reduce exposure |
| MFIC | SELL | EXIT | 770 | Market | Failed thesis | - | - | No catalyst, -5.7% loss |
| BYND | SELL | EXIT | 500 | Market | Risk mgmt | - | - | Bankruptcy risk too high |
| IONQ | SELL SHORT | SHORT | 150 | $47.50 | Bubble | $55 | $35 | Quantum bubble bursting |
| PATH | BUY | LONG | 400 | $17.00 | AI adoption | $15.50 | $20 | Automation AI winner |
| XBI | BUY | LONG | 70 | $94.50 | JPM Conf | $90 | $102 | Biotech conference play |
| MRNA | BUY | LONG | 200 | $31.25 | Q1 data | $28 | $36 | Oversold with catalysts |
| RGTI | SELL SHORT | SHORT | 250 | $23.50 | Bubble | $28 | $15 | No revenue quantum hype |
| AFRM | BUY | LONG | 80 | $75.00 | BNPL growth | $69 | $85 | Fintech momentum |
| OXY | SELL SHORT | SHORT | 150 | $46.50 | Oil weak | $50 | $42 | Energy sector breakdown |

---

## 11. EXACT ORDER BLOCK

### EXITS (Execute First - Generate Cash)

```
Action: sell
Ticker: ZM
Shares: 300
Order type: limit
Limit price: $87.75
Time in force: DAY
Intended execution date: 2025-12-26
Catalyst date: NA
Stop loss: NA
Target price: NA
One-line rationale: Emergency position size reduction from 30.9% overweight
```

```
Action: sell
Ticker: ARWR  
Shares: 12
Order type: limit
Limit price: $69.75
Time in force: DAY
Intended execution date: 2025-12-26
Catalyst date: 2026-01-07
Stop loss: NA
Target price: NA
One-line rationale: Trim 50% of +74% winner before JPM Healthcare Conference volatility
```

```
Action: sell
Ticker: ARQT
Shares: 35  
Order type: limit
Limit price: $29.10
Time in force: DAY
Intended execution date: 2025-12-26
Catalyst date: NA
Stop loss: NA
Target price: NA
One-line rationale: Profit-taking rule on +46% gain, trim half position
```

```
Action: sell
Ticker: GKOS
Shares: 15
Order type: limit  
Limit price: $115.75
Time in force: DAY
Intended execution date: 2025-12-26
Catalyst date: NA
Stop loss: NA
Target price: NA
One-line rationale: Trim 50% of +32% winner per profit-taking rules
```

```
Action: sell
Ticker: PLUG
Shares: 2500
Order type: limit
Limit price: $2.09
Time in force: DAY  
Intended execution date: 2025-12-26
Catalyst date: NA
Stop loss: NA
Target price: NA
One-line rationale: Reduce speculative hydrogen position by half, no near catalyst
```

```
Action: sell
Ticker: MFIC
Shares: 770
Order type: limit
Limit price: $11.44
Time in force: DAY
Intended execution date: 2025-12-26
Catalyst date: NA
Stop loss: NA  
Target price: NA
One-line rationale: Exit -5.7% loser with no catalyst or momentum
```

```
Action: sell
Ticker: BYND
Shares: 500
Order type: limit
Limit price: $0.94
Time in force: DAY
Intended execution date: 2025-12-26  
Catalyst date: NA
Stop loss: NA
Target price: NA
One-line rationale: Exit bankruptcy risk position, preserve capital
```

### NEW POSITIONS (After Exits Clear)

```
Action: sell_to_open
Ticker: IONQ
Shares: 150
Order type: limit
Limit price: $47.50
Time in force: GTC
Intended execution date: 2025-12-27
Catalyst date: 2026-02-15
Stop loss: $55.00
Target price: $35.00
One-line rationale: Short quantum computing bubble before February lockup expiration
```

```
Action: buy
Ticker: PATH
Shares: 400
Order type: limit
Limit price: $17.00
Time in force: GTC  
Intended execution date: 2025-12-27
Catalyst date: 2026-02-12
Stop loss: $15.50
Target price: $20.00
One-line rationale: Automation AI adoption accelerating into Feb 12 earnings
```

```
Action: buy
Ticker: XBI
Shares: 70
Order type: limit
Limit price: $94.50
Time in force: GTC
Intended execution date: 2025-12-27
Catalyst date: 2026-01-07  
Stop loss: $90.00
Target price: $102.00
One-line rationale: Biotech ETF for JPM Healthcare Conference Jan 7-10 catalyst
```

```
Action: buy
Ticker: MRNA
Shares: 200
Order type: limit
Limit price: $31.25
Time in force: GTC
Intended execution date: 2025-12-27
Catalyst date: 2026-03-15
Stop loss: $28.00
Target price: $36.00
One-line rationale: Oversold mRNA leader with Q1 cancer vaccine data catalyst
```

```
Action: sell_to_open  
Ticker: RGTI
Shares: 250
Order type: limit
Limit price: $23.50
Time in force: GTC
Intended execution date: 2025-12-27
Catalyst date: 2026-01-31
Stop loss: $28.00
Target price: $15.00
One-line rationale: Short quantum bubble stock with no revenue or viable product
```

```
Action: buy
Ticker: AFRM
Shares: 80
Order type: limit
Limit price: $75.00
Time in force: GTC
Intended execution date: 2025-12-27
Catalyst date: 2026-02-08  
Stop loss: $69.00
Target price: $85.00
One-line rationale: BNPL leader riding fintech momentum into Q4 earnings
```

```
Action: sell_to_open
Ticker: OXY
Shares: 150  
Order type: limit
Limit price: $46.50
Time in force: GTC
Intended execution date: 2025-12-27
Catalyst date: 2026-01-31
Stop loss: $50.00
Target price: $42.00
One-line rationale: Short energy weakness with Buffett reducing stake signal
```

### OPTIONS TRADES

```
Action: buy_to_open
Ticker: XBI
Option: CALL $95 2026-01-17
Order type: limit
Limit price: $3.50
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2026-01-07
Stop loss: $1.75
Target price: $5.25
One-line rationale: Long biotech calls for JPM Healthcare Conference week
```

```
Action: sell_to_open
Ticker: XBI
Option: CALL $100 2026-01-17
Order type: limit
Limit price: $1.50  
Time in force: DAY
Intended execution date: 2025-12-27
Catalyst date: 2026-01-07
Stop loss: NA
Target price: $0.75
One-line rationale: Complete bull call spread for defined risk JPM play
```

---

## 12. RISK MANAGEMENT

**Position Limits:**
- **Max Position**: $10,000 (10% of capital) - ZM violation fixed
- **Max Sector**: 25% concentration - Biotech at 21% post-rebalance
- **Max Shorts**: 35% of portfolio - Currently 27% short exposure

**Stop Loss Discipline:**
- **Long Stocks**: 12% trailing stop
- **Short Stocks**: 15% stop (tighter due to unlimited risk)
- **Options**: 50% of premium paid

**Risk Metrics:**
- **Daily Loss Limit**: $5,000 (4.4% of portfolio)
- **Weekly Loss Limit**: $10,000 (8.8% of portfolio)  
- **Cash Buffer**: Target $15,000-25,000 (achieved post-rebalance)

**Volatility Management:**
- Holiday week = Reduce position sizes
- Wide bid-ask spreads = Use limit orders only
- Low volume = Avoid illiquid names

**Correlation Risk:**
- Tech longs: DOCU, PATH, AFRM (monitor sector exposure)
- Energy shorts: CVX, CIVI, OXY (working well)
- Biotech longs: ARWR, BEAM, INCY, XBI (JPM Conference risk)

**Black Swan Protection:**
- SPY collar in place
- 25% short exposure provides hedge
- Cash buffer for margin calls

**Key Risk Factors:**
1. **OVERCONCENTRATION FIXED**: ZM from 30.9% â†’ 7.7%
2. **QUANTUM BUBBLE**: IONQ/RGTI shorts could squeeze
3. **BIOTECH BINARY**: JPM Conference high volatility
4. **HOLIDAY LIQUIDITY**: Wider spreads, failed fills

**CRITICAL DISCIPLINES:**
- NO FOMO on quantum computing longs
- STRICT STOPS on all shorts
- SCALE INTO new positions
- PROTECT WINNERS with trailing stops

**Next Week Focus:**
1. Execute rebalancing plan immediately
2. Position for JPM Healthcare Conference
3. Monitor quantum bubble for short entries
4. Prepare for January catalyst surge

---

**FINAL NOTES**: Portfolio desperately needed rebalancing with ZM at 30.9% weight. After trades execute, we'll have proper diversification, $45-50K cash buffer, and positioned for January's catalyst-rich environment. The quantum computing bubble presents exceptional short opportunities while biotech sets up for JPM Conference fireworks. Energy shorts continue working - ride the trend. Next week starts 2026 with massive catalyst potential.